Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision

被引：0
作者：
Marisa Donada
Serena Bonin
Renzo Barbazza
Daniel Pettirosso
Giorgio Stanta
机构：
[1] University of Trieste,DSM Department (Department of medical, surgical and health sciences)
[2] Surgical Pathology Bldg,undefined
来源：
BMC Gastroenterology | / 13卷
关键词：
Colon cancer; Stage II; Adjuvant therapy; 5-Fluorouracil; Formalin-fixed and paraffin-embedded tissues; Thymidylate synthase; MMR; CIMP;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Biomarkers and stage II colorectal cancer therapy
    Zijoo, Ritika
    Olszanski, Anthony J.
    Weinberg, David S.
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S84 - S86
  • [22] Optimal Duration of Adjuvant Therapy for Stage III Colon Cancer
    Kadakia, Kunal C.
    Worrilow, William M.
    Coley, Harris
    Salem, Mohammed E.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (05) : 289 - 298
  • [23] Stage II colon cancer
    Church, David N.
    Midgley, Rachel
    Kerr, David J.
    CHINESE CLINICAL ONCOLOGY, 2013, 2 (02)
  • [24] Current Status of Gene Expression Profiling to Assist Decision Making in Stage II Colon Cancer
    Chee, Cheng E.
    Meropol, Neal J.
    ONCOLOGIST, 2014, 19 (07) : 704 - 711
  • [25] Application of Microsatellite Instability and Oncotype DX in Stage II Colon Cancer Adjuvant Chemotherapy
    Chu, Edward
    CURRENT COLORECTAL CANCER REPORTS, 2011, 7 (04) : 260 - 266
  • [26] FOLFOX and FLOX Regimens for the Adjuvant Treatment of Resected Stage II and III Colon Cancer
    Sharif, Saima
    O'Connell, Michael J.
    Yothers, Greg
    Lopa, Samia
    Wolmark, Norman
    CANCER INVESTIGATION, 2008, 26 (09) : 956 - 963
  • [27] Defining a high-risk subgroup with colon cancer stages I and II for possible adjuvant therapy
    Gertler, Ralf
    Rosenberg, Robert
    Schuster, Tibor
    Friess, Helmut
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (17) : 2992 - 2999
  • [28] The role of adjuvant chemotherapy in stage II and III mucinous colon cancer
    Fields, Adam C.
    Lu, Pamela
    Goldberg, Joel
    Irani, Jennifer
    Bleday, Ronald
    Melnitchouk, Nelya
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (07) : 1190 - 1200
  • [29] Decision-making under clinical uncertainty: An in-depth examination of provider perspectives on adjuvant chemotherapy for stage II colon cancer
    Shelton, Rachel C.
    Brotzman, Laura E.
    Crookes, Danielle M.
    Robles, Patrick
    Neugut, AIfred I.
    PATIENT EDUCATION AND COUNSELING, 2019, 102 (02) : 284 - 290
  • [30] Adjuvant chemotherapy improves survival in patients with American Joint Committee on Cancer stage II colon cancer
    McKenzie, Shaun
    Nelson, Rebecca
    Mailey, Brian
    Lee, Wendy
    Chung, Vincent
    Shibata, Stephen
    Garcia-Aguilar, Julio
    Kim, Joseph
    CANCER, 2011, 117 (24) : 5493 - 5499
12345